ClinConnect ClinConnect Logo
Search / Trial NCT07107295

Thoracolumbar Fascia Thickness in Chronic Stroke Patients

Launched by ANKARA UNIVERSITY · Jul 30, 2025

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a part of the body called the thoracolumbar fascia, which is a layer of tissue in the lower back, to see how thick it is in people who have had a stroke more than six months ago. The study aims to understand how the thickness and flexibility of this tissue relate to important abilities like balance, trunk (core) control, flexibility, and how independently someone can carry out daily activities after a stroke.

People who might be eligible for this study are adults between 40 and 70 years old who have been diagnosed with a stroke by a doctor, have a certain level of thinking ability (measured by a simple test), and have mild to moderate disability from their stroke. Participants will undergo non-invasive tests, including an ultrasound to measure the tissue thickness, and simple physical tests to check their balance, trunk movement, and independence in daily tasks. It’s important to note that people who can’t speak, have severe vision problems, other serious neurological conditions, or heart failure, or who are advised not to exercise, will not be able to join. This study is not yet recruiting participants but aims to help improve understanding of stroke recovery and support better rehabilitation strategies in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between 40 and 70 years old.
  • Being diagnosed with a stroke by a neurologist.
  • Scoring above 21 on the Montreal Cognitive Assessment Scale.
  • Scoring between 0 and 3 on the Modified Rankin Scale.
  • Being at least 6 months past the stroke
  • Exclusion Criteria:
  • Inability to communicate verbally
  • Individuals with severe visual impairment, neurological disorders in addition to stroke, and/or congestive heart failure
  • Patients in whom exercise is not recommended.

About Ankara University

Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Süleyman Korkusuz, PhD

Study Chair

Atılım University

Büşra Seçkinoğulları Korkusuz, PhD

Principal Investigator

Ankara University

Ayşenur Özcan, MSc

Study Chair

Çankırı Karatekin University

Ali Mert Özcan, MSc

Study Chair

Baskent University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported